Panagiotis D. Kottaridis
Department of Haematology
Royal Free and University College London Medical School
98 Chenies Mews
London WC1E 6HX
UK
Name/email consistency: high
- Prognostic implications of the presence of FLT3 mutations in patients with acute myeloid leukemia. Kottaridis, P.D., Gale, R.E., Linch, D.C. Leuk. Lymphoma (2003)
- Survival and freedom from progression in autotransplant lymphoma patients is independent of stem cell source: further follow-up from the original randomised study to assess engraftment. Kottaridis, P.D., Peggs, K., Schmitz, N., Dreger, P., Boogaerts, M.A., Ferrant, A., Demuynck, H.M., Zander, A., Link, H., Matcham, J., Linch, D.C., Borkett, K., Goldstone, A.H. Leuk. Lymphoma (2002)
- Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors. Kottaridis, P.D., Gale, R.E., Langabeer, S.E., Frew, M.E., Bowen, D.T., Linch, D.C. Blood (2002)
- The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Kottaridis, P.D., Gale, R.E., Frew, M.E., Harrison, G., Langabeer, S.E., Belton, A.A., Walker, H., Wheatley, K., Bowen, D.T., Burnett, A.K., Goldstone, A.H., Linch, D.C. Blood (2001)
